U.S. Markets closed

Can Edwards Lifesciences See Robust Net Profit Margin in 2017?

Margaret Patrick

In its 2Q17 earnings conference call, Edwards Lifesciences (EW) projected 2017 adjusted EPS to fall to $3.65–$3.85, which is higher than the previous $3.43–$3.55.